Ibnsina Pharma Stock price

Equities

ISPH

EGS512O1C012

Drug Retailers

End-of-day quote Egyptian Exchange 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
2.56 EGP -5.19% Intraday chart for Ibnsina Pharma 0.00% -18.47%
Sales 2024 * 37.57B 798M Sales 2025 * 44.09B 936M Capitalization 2.72B 57.78M
Net income 2024 * 316M 6.71M Net income 2025 * 417M 8.85M EV / Sales 2024 * 0.17 x
Net Debt 2024 * 3.72B 78.98M Net Debt 2025 * 3.56B 75.62M EV / Sales 2025 * 0.14 x
P/E ratio 2024 *
9 x
P/E ratio 2025 *
7.01 x
Employees 5,500
Yield 2024 *
1.44%
Yield 2025 *
2.86%
Free-Float 60.26%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.53%
1 week+5.47%
Current month-28.95%
1 month-26.03%
3 months-14.01%
6 months+35.68%
Current year-14.01%
More quotes
1 week
2.63
Extreme 2.63
2.90
1 month
2.52
Extreme 2.52
3.87
Current year
2.51
Extreme 2.51
4.15
1 year
1.36
Extreme 1.362
4.15
3 years
1.10
Extreme 1.101
4.15
5 years
1.10
Extreme 1.101
8.38
10 years
1.10
Extreme 1.101
8.77
More quotes
Managers TitleAgeSince
Chief Executive Officer - 00-12-17
Chief Executive Officer - 00-12-17
Director of Finance/CFO - -
Members of the board TitleAgeSince
Director/Board Member - -
Chief Executive Officer - 00-12-17
Chief Executive Officer - 00-12-17
More insiders
Date Price Change Volume
24-03-27 2.56 -5.19% 9 369 508
24-03-27 2.7 -2.53% 10,467,700
24-03-26 2.77 -2.12% 16,162,580
24-03-25 2.83 +5.20% 14,811,050
24-03-24 2.69 +1.13% 14,637,520

End-of-day quote Egyptian Exchange, March 26, 2024

More quotes
Ibnsina Pharma S.A.E. is Egypt's number two in the wholesale distribution of pharmaceutical products. The group offers medicines and cosmetics to more than 35,000 private and public sector customers (distribution chains, pharmacies, wholesalers and health establishments) through 55 sites located in Egypt.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
2.7 EGP
Average target price
4.08 EGP
Spread / Average Target
+51.11%
Consensus

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Ibnsina Pharma - Egyptian Exchange